Shelton Capital Management Eli Lilly & CO Transaction History

Shelton Capital Management

$3.85 Billion
Q3 2024

A detailed history of Shelton Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Shelton Capital Management holds 16,789 shares of LLY stock, worth $13.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

16,789

Previous 21,536 22.04%

Holding current value

$13.4 Million

Previous $19.5 Million 23.72%

% of portfolio

0.39%

Previous 0.54%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $3.67 Million - $4.56 Million	-4,747 Reduced 22.04%	16,789 $14.9 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $313,143 - $392,705	-432 Reduced 1.97%	21,536 $19.5 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $769,860 - $1.03 Million	-1,300 Reduced 5.59%	21,968 $17.1 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $850,807 - $1 Million	1,620 Added 7.48%	23,268 $13.6 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $86,940 - $119,859	-200 Reduced 0.92%	21,648 $11.6 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $3.27 Million - $4.37 Million	-9,322 Reduced 29.91%	21,848 $10.2 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $4.96 Million - $5.83 Million	15,970 Added 105.07%	31,170 $10.7 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $151,771 - $176,844	472 Added 3.2%	15,200 $5.56 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.88 Million - $2.14 Million	6,340 Added 75.58%	14,728 $4.76 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $501,714 - $589,086	-1,800 Reduced 17.67%	8,388 $2.72 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $243,287 - $301,921	-1,082 Reduced 9.6%	10,188 $2.81 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.01 Million - $1.24 Million	-4,565 Reduced 28.83%	11,270 $2.6 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $144,440 - $186,832	-800 Reduced 4.81%	15,835 $3.63 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $834,909 - $1.08 Million	5,081 Added 43.98%	16,635 $3.11 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $996,062 - $1.32 Million	-7,635 Reduced 39.79%	11,554 $1.95 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $64,775 - $74,924	-443 Reduced 2.26%	19,189 $2.84 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $162,066 - $195,045	-1,188 Reduced 5.71%	19,632 $3.22 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $416,675 - $515,725	3,500 Added 20.21%	20,820 $2.89 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $218,437 - $270,554	-2,043 Reduced 10.55%	17,320 $2.28 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $106,790 - $116,160	-1,000 Reduced 4.91%	19,363 $2.17 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $1.95 Million - $2.28 Million	17,639 Added 647.54%	20,363 $2.26 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $1.54 Million - $1.81 Million	-13,815 Reduced 83.53%	2,724 $21 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $225,567 - $252,703	-2,130 Reduced 11.41%	16,539 $1.91 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $4.65 Million - $5.81 Million	-54,122 Reduced 74.35%	18,669 $2 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $4.58 Million - $5.25 Million	60,450 Added 489.83%	72,791 $6.21 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $170,683 - $201,480	2,300 Added 22.91%	12,341 $955,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $1,001 - $1,112	-13 Reduced 0.13%	10,041 $859,000
Q2 2017 Aug 14, 2017	BUY	N/A	213 Added 2.16%	10,054 $827,000
Q1 2017 Nov 28, 2017	SELL	N/A	-751 Reduced 7.09%	9,841 $828,000
Q4 2016 Nov 29, 2017	SELL	N/A	-2,200 Reduced 17.2%	10,592 $779,000
Q3 2016 Dec 06, 2017	BUY	N/A	2,200 Added 20.77%	12,792 $1.03 Million
Q3 2016 Dec 04, 2017	BUY	N/A	10,592	10,592 $779,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account

Shelton Capital Management Eli Lilly & CO Transaction History